TYMS and colorectal carcinoma: A previous study showed that a derivative of butyrate inhibits the mRNA level expression of TYMS and may have a synergistic effect with 5-FU on apoptosis in CRC, suggesting that NaB may serve as a potential therapeutic adjuvant for 5-FU [17].